NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,195,578 | +59.7% | 247,469 | +58.2% | 0.04% | +32.1% |
| Q2 2023 | $15,780,887 | +23.3% | 156,433 | +12.6% | 0.03% | +16.7% |
| Q1 2023 | $12,797,527 | +3.9% | 138,956 | +2.3% | 0.02% | -4.0% |
| Q4 2022 | $12,319,423 | +16.4% | 135,789 | -2.5% | 0.02% | +4.2% |
| Q3 2022 | $10,583,000 | -9.8% | 139,219 | +0.3% | 0.02% | -7.7% |
| Q2 2022 | $11,735,000 | -1.6% | 138,743 | +6.6% | 0.03% | +13.0% |
| Q1 2022 | $11,926,000 | +9.2% | 130,133 | +4.3% | 0.02% | +9.5% |
| Q4 2021 | $10,918,000 | +12.9% | 124,792 | +5.5% | 0.02% | +5.0% |
| Q3 2021 | $9,674,000 | -13.3% | 118,256 | -3.3% | 0.02% | -16.7% |
| Q2 2021 | $11,159,000 | +8.7% | 122,273 | +1.9% | 0.02% | -4.0% |
| Q1 2021 | $10,269,000 | -17.3% | 120,045 | -8.7% | 0.02% | -24.2% |
| Q4 2020 | $12,412,000 | +10.1% | 131,446 | +1.4% | 0.03% | -2.9% |
| Q3 2020 | $11,275,000 | -2.1% | 129,624 | -1.6% | 0.03% | -12.8% |
| Q2 2020 | $11,515,000 | -1.7% | 131,740 | -42.5% | 0.04% | -18.8% |
| Q1 2020 | $11,712,000 | – | 229,306 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |